Analyst firms · Robert W. Baird · SGFY

Robert W. Baird SGFY price target and rating history

Signify Health Inc. (SGFY) · Technology

Robert W. Baird rates Signify Health Inc. (SGFY) Outperform with a $16 price target, as of its latest action on May 16, 2022. It has published 3 rating actions on SGFY since September 2021, including 1 upgrade and 2 downgrades.

Current rating
Outperform
Price target
$16
Median target, all firms
Too few
Actions on SGFY
3

Robert W. Baird price target on SGFY

$24$20$1620222023202420252026
Robert W. Baird price target on SGFY, each point a stated target, September 2021 to May 2022.

Every Robert W. Baird rating on SGFY

Questions about Robert W. Baird and SGFY

What is Robert W. Baird's price target for SGFY?
Robert W. Baird's latest stated price target for Signify Health Inc. (SGFY) is $16, from its action on May 16, 2022.
What is Robert W. Baird's rating on SGFY?
Robert W. Baird rates SGFY Outperform, a bullish rating, as of May 16, 2022.
When did Robert W. Baird last change its view on SGFY?
On May 16, 2022, Robert W. Baird upgrades to Outperform from Neutral, price target $19 to $16.

All Robert W. Baird ratingsSGFY news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.